GERMANTOWN, Md. , Nov. 12, 2024 /PRNewswire/ -- Precigen, Inc.
(Nasdaq: PGEN ), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari , PhD, President and CEO of Precigen, will participate in a fireside chat on Tuesday, November 19, 2024 from 10:55 to 11:25 AM ET at the Stifel 2024 Healthcare Conference taking place November 18 to 19, 2024 in New York . Event details can be found on Precigen's website in the Events & Presentations section at investors.precigen.
com/events-presentations . Precigen: Advancing Medicine with Precision ® Precigen (Nasdaq: PGEN ) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target the most urgent and intractable diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner.
Precigen operates as an innovation engine progressing a preclinical and clinical pipeline of well-differentiated therapies toward clinical proof-of-concept and commercialization. For more information about Precigen, visit www.precigen.
com or follow us on LinkedIn or YouTube . Cautionary Statement Regarding Forward-Looking Statements Some of the statements made in this press release are forward-looking statemen.
